IP Library Patent Application 11814807
Patent Application
App. No. 11/814,807

DEVICE FOR DETECTING AN ENZYME IN A SAMPLE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/814,807
Abstract

A device for detecting a mammalian host-derived enzyme in a sample of a wound fluid, said device comprising: a housing having an inlet for the sample and side walls defining a fluid flow path extending from said inlet an indicator moiety that is bound to a solid substrate by means of a peptide linker moiety that is cleavable by said host-derived enzyme, said solid substrate being located in a reaction zone of said fluid flow path; and a detector moiety located in a detection zone downstream from the reaction zone in said fluid flow path, wherein the detector moiety interacts with an indicator moiety that has been cleaved from said solid substrate to produce a detectable change in said detection zone. Suitably, the device further comprises a control moiety located in a control zone in said device, wherein the control moiety can interact with a component of the wound fluid sample to improve the accuracy of the device. Also provided are systems comprising a device of the invention and a swab or biopsy punch adapted for use therewith.

Claims (26)

1 . A device for detecting a mammalian host-derived or an analyte enzyme in a sample of a wound fluid, said device comprising:

a housing having an inlet for the sample and side walls defining a fluid flow path extending from said inlet

an indicator moiety that is bound to a solid substrate by means of a peptide linker moiety that is cleavable by said host-derived enzyme, said solid substrate being located in a reaction zone of said fluid flow path; and

a detector moiety located in a detection zone downstream from the reaction zone in said fluid flow path, wherein the detector moiety interacts with an indicator moiety that has been cleaved from said solid substrate to produce a detectable change in said detection zone.

2 . The device according to claim 1 , wherein said mammalian host-derived enzyme is selected from the group consisting of neutrophil elastase, matrix metalloproteinases (including the group consisting of MMP-9, MMP-8, MMP-1, MMP-2 and MMP-12), proteinase 3, plasmin, low molecular weight gelatinases and latent or active elastases, interleukin converting enzymes, tumor necrosis factor (TNFα) converting enzymes, and mixtures thereof

3 . The device according to claim 1 , wherein the device further comprises a control moiety located in a control zone in said device, wherein the control moiety can interact with a component of the wound fluid sample to improve the accuracy of the device.

4 . The device according to claim 1 , wherein the device further comprises

a control moiety located in a control zone in said device, wherein the control moiety can interact with a component of the wound fluid sample to improve the accuracy of the device.

5 . The device according to claim 4 , wherein said enzyme is selected from the group consisting of mammalian host-derived enzymes and bacterial enzymes.

6 . The device according to claim 5 , wherein said enzyme comprises a bacterial enzyme selected from the group consisting of bacterial protease enzymes of Pseudomonas Aeruginosa, Enterococcus faecalis, Escherichia Coli, Streptococcus Pyogenes and Staphylococcus Aureus.

7 . (canceled)

8 . The device according to claim 1 , wherein the fluid flow path contains one or more porous carrier materials.

9 . The device according to claim 1 , wherein the fluid flow path comprises a sample application zone in fluid communication with said inlet, and the reaction zone is located downstream from the sample application zone.

10 . The device according to claim 9 , wherein the fluid flow path contains a hydrophilic, porous wicking pad in said sample application zone.

11 . The device according to claim 1 , wherein the fluid flow path contains an absorbent reservoir of a porous hydrophilic material at the downstream end of the fluid flow path.

12 . The device according to claim 1 , wherein the indicator moiety comprises an indicator enzyme, and said detector moiety comprises a substrate for the indicator enzyme.

13 . The device according to claim 1 , wherein the device further comprises at least one filtration element to remove impurities from the sample before the sample contacts the reaction zone.

14 . The device according to claim 1 , wherein the device comprises an end-of-assay indicator to indicate when a predetermined minimum volume of liquid has passed through the reaction zone.

15 . The device according to claim 1 , wherein the device comprises a reference assay element for establishing that the total protease content or the total protein content of the sample is higher than a predetermined minimum.

16 . The device according to claim 1 , wherein the device comprises a buffer zone in the flow path upstream of the detection zone and downstream of the reaction zone, wherein the buffer zone is adapted to bind or inactivate a predetermined minimum amount the detector moiety.

17 . The device according to claim 1 , wherein the device comprises a control zone in the flow path upstream of the reaction zone, wherein the control zone is adapted to bind or inactivate one or more interfering enzymes.

18 . The device according to claim 1 , wherein the device comprises a plurality of different said peptide linkers for detecting a plurality of different analyte enzymes.

19 . The device according to claim 18 , wherein the device comprises a plurality of fluid flow paths each having a different peptide linker group in its respective reaction zone for detecting a different enzyme.

20 . The device according to claim 19 , wherein said plurality of fluid flow paths are radially distributed around a single sample receiving port.

21 . (canceled)

22 . (canceled)

Assignments (8)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Feb 6, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: KCI LICENSING, INC., AS GRANTOR; TECHNIMOTION, LLC, A DELAWARE LIMITED LIABILITY COMPANY, AS GRANTOR; SYSTAGENIX WOUND MANAGEMENT (US), INC., A DELAWARE CORPORATION, AS GRANTOR
Reel/Frame 041395/0044 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE RECEIVING PARTY PREVIOUSLY RECORDED AT REEL: 033681 FRAME: 0939. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 18, 2014
From: SYSTAGENIX WOUND MANAGEMENT (US), INC
To: WOUNDCHEK LABORATORIES (US), INC
Reel/Frame 033766/0344 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2014
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.
To: WOUNDCHECK LABORATORIES (US), INC.
Reel/Frame 033681/0939 →
SECURITY AGREEMENT Recorded Oct 29, 2013
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 031508/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2013
From: BAYLIFF, SIMON W.; ESSLER, ALICIA; GREENHALGH, DAVID; BIOTT, MAURICE C.
To: ETHICON, INC.
Reel/Frame 029903/0188 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2010
From: ETHICON, INC.; JOHNSON & JOHNSON MEDICAL, LIMITED
To: SYSTAGENIX WOUND MANAGEMENT (US), INC.
Reel/Frame 024823/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2010
From: ETHICON, INC.; JOHNSON & JOHNSON MEDICAL LIMITED
To: SYSTAGENIX WOUND MANAGEMENT IP CO. B.V.
Reel/Frame 024563/0344 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2010
From: ETHICON, INC.; JOHNSON & JOHNSON; JOHNSON & JOHNSON MEDICAL LIMITED; JOHNSON & JOHNSON MEDICAL B.V.; JANSSEN PHARMACEUTICA N.V.; CILAG AG; CILAG HOLDING AG; JEVCO LIMITED
To: SYSTAGENIX WOUND MANAGEMENT (US), INC.; SYSTAGENIX WOUND MANAGEMENT IP CO. B.V.
Reel/Frame 024563/0368 →